Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation

References

• HungHYOhkoshiEGotoMBastowKFNakagawa-GotoKLeeKHAntitumor agents. 293. nontoxic dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethy-lenedioxybiphenyl-2,2′-dicarboxylate (DDB) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugsJ Med Chem2012555413542410.1021/jm300378k22612652
   PubMed Web of Science ®Google Scholar
• KanwalRGuptaSEpigenetic modifications in cancerClin Genet20128130331110.1111/j.1399-0004.2011.01809.x22082348
   PubMed Web of Science ®Google Scholar
• BosettiCRosatoVGallusSCuzickJLa VecchiaCAspirin and cancer risk: a quantitative review to 2011Ann Oncol2012231403141510.1093/annonc/mds11322517822
   PubMed Web of Science ®Google Scholar
• AugustinHGAntiangiogenic tumour therapy: will it work?Trends Pharmacol Sci19981921622210.1016/S0165-6147(98)01211-59666712
   PubMed Web of Science ®Google Scholar
• CaletaIKraljMMarjanovicMNovel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysisJ Med Chem2009521744175610.1021/jm801566q19265399
   PubMed Web of Science ®Google Scholar
• CiardielloFTortoraGA novel approach in the treatment of cancer: targeting the epidermal growth factor receptorClin Cancer Res200172958297011595683
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev2004561649165910.1016/j.addr.2004.02.01415350294
   PubMed Web of Science ®Google Scholar
• AirdRECummingsJRitchieAAIn vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancerBr J Cancer2002861652165710.1038/sj.bjc.660029012085218
   PubMed Web of Science ®Google Scholar
• PreethaAAjaikumarBKChitraSCancer is a preventable disease that requires major lifestyle changesPharm Res2008252097211610.1007/s11095-008-9661-918626751
   PubMed Web of Science ®Google Scholar
• Mei-HuaXGui-YingZEffect of indomethacin on cell cycle proteins in colon cancer cell linesWorld J Gastroenterol20052116931696
   Google Scholar
• KolonelLNAltshulerDHendersonBEThe multiethnic cohort study: exploring genes, lifestyle and cancer riskNat Rev Cancer2004451952710.1038/nrc138915229477
   PubMed Web of Science ®Google Scholar
• CashmanJNThe mechanisms of action of NSAIDs in analgesiaDrugs199652Supplement 5132310.2165/00003495-199600525-000048922554
   PubMed Web of Science ®Google Scholar
• LiggettJLZhangXElingTEBaekSJAnti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsCancer Lett201434621722410.1016/j.canlet.2014.01.02124486220
   PubMed Web of Science ®Google Scholar
• KonturekPCKonturekSJBielanskiWInfluence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patientsDig Dis Sci2003482005201714627349
   PubMed Web of Science ®Google Scholar
• KraljMKapitanovicSKovacevicDLukacJSpaventiSPavelicKEffect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cellsJ Cancer Res Clin Oncol200112717317911260862
   PubMed Web of Science ®Google Scholar
• LeungWKBaiAHChanVYEffect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cellsGut20045333133814960510
   PubMed Web of Science ®Google Scholar
• ZaridzeDBorisovaEMaximovitchDChkhikvadzeVAspirin protects against gastric cancer: results of a case-control study from Moscow, RussiaInt J Cancer19998247347610404057
   PubMed Web of Science ®Google Scholar
• AkreKEkstromAMSignorelloLBHanssonLENyrenOAspirin and risk for gastric cancer: a population-based case-control study in SwedenBr J Cancer20018496596810.1054/bjoc.2001.170211286478
   PubMed Web of Science ®Google Scholar
• GurpinarEGrizzleWEPiazzaGANSAIDs inhibit tumorigenesis, but how?Clin Cancer Res2014201104111310.1158/1078-0432.CCR-13-157324311630
   PubMed Web of Science ®Google Scholar
• TinsleyHNPiazzaGANovel Therapeutics: Sulindac, Derivatives, and PhosphodiesterasesCurr Colorectal Cancer Rep20184325330
   Google Scholar
• MurphyJAnti-cancer therapy: non-steroidal anti-inflammatory drugs (NSAIDS) in combination with immunotherapyMOJ Immunol201750015610.15406/moji.2017.05.00156
   Google Scholar
• YinTWangGYeTWangYSulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulatorSci Rep201661953410.1038/srep1953426777116
   PubMed Web of Science ®Google Scholar
• VainioHMorganGNon-steroidal anti-inflammatory drugs and chemoprevention of cancerAnn Chir Gynaecol20008917317611079784
   PubMedGoogle Scholar
• DempkeWRieCGrotheyASchmollHJCyclooxygenase-2: a novel target for cancer chemotherapyJ Cancer Res Clin Oncol200112741141711469677
   PubMed Web of Science ®Google Scholar
• JollyKChengKKLangmanMJSNSAIDs and gastrointestinal cancer preventionDrugs20026294595610.2165/00003495-200262060-0000611929340
   PubMed Web of Science ®Google Scholar
• MarjanovicMBrankaZLanaPMarijanaZMarijetaKFenoprofen and ketoprofen amides as potential antitumor agentsChem Biol Drug Des20076922222610.1111/j.1747-0285.2007.00494.x17441909
   PubMed Web of Science ®Google Scholar
• HellbergMRNamilADelgadoPNovel esters and amides of nonsteroidal antiinflammatory carboxylic acids as antioxidants and antiproliferative agentsJ Med Chem19994226727610.1021/jm980430o9925732
   PubMed Web of Science ®Google Scholar
• LengauerTRareyMComputational methods for biomolecular dockingCurr Opin Struct Biol199664024068804827
   PubMed Web of Science ®Google Scholar
• WangHDommertFHolmCOptimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiencyJ Chem Phys201013303411710.1063/1.344681220649318
   PubMed Web of Science ®Google Scholar
• NunesBSCarvalhoFDGuilherminoLMVanSGUse of the genus Artemia in ecotoxicity testingEnviron Pollut200614445346210.1016/j.envpol.2005.12.03716677747
   PubMed Web of Science ®Google Scholar
• LiebermanMA brine shrimp bioassay for measuring toxicity and remediation of chemicalsJ Chem Educ1999761689169110.1021/ed076p1689
   Web of Science ®Google Scholar
• SleetRBBrendelKImproved methods for harvesting and counting synchronous populations of artemia nauplii for use in developmental toxicologyEcotoxicol Environ Saf1983743544610.1016/0147-6513(83)90082-96641581
   PubMed Web of Science ®Google Scholar
• GalskyAGKozimorRPiotrowskiDPowellRGThe crown-gall potato disk bioassay as a primaryscreen for compounds with antitumor activityJ Natl Cancer Inst1981676896926944538
   PubMedGoogle Scholar
• KitchenDBDecornezHFurrJRBajorathJDocking and scoring in virtual screening for drug discovery: methods and applicationsNat Rev Drug Discov2004393594410.1038/nrd154915520816
   PubMed Web of Science ®Google Scholar
• MeyerBNFerrigniNRPutnamJEJacobsenLBNicholsDEMcLaughlinJLBrine shrimp: a convenient general bioassay for active plant constituentsPlanta Med198245313410.1055/s-2007-971236
   PubMed Web of Science ®Google Scholar
• RehmanAChoudharyMIBioassay Techniques for Drug DevelopmentAmsterdamHarwood Academic Publishers2001914
   Google Scholar
• AshrafZAlamgeerMKHassanMFlurbiprofen-antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modelingDrug Des Devel Ther2016102401241910.2147/DDDT.S109318
   PubMed Web of Science ®Google Scholar
• PettersenEFGoddardTDHuangCCUCSF Chimera – a visualization system for exploratory research and analysisJ Comput Chem200625131605161210.1002/jcc.20084
   Web of Science ®Google Scholar
• MonkAScudieroDASkehanPShoemakerRHPaullKDDTP, DCTD tumor repository a catalog of in vitro cell lines, transplantable animal and human tumors and micro assaysJ Natl Cancer Inst1991837572041050
   PubMedGoogle Scholar
• LovellSCDavisIWArendallWBIIIStructure validation by Cα geometry: φ, ψ and Cβ deviationProteins20025043745010.1002/prot.10286
   Web of Science ®Google Scholar
• ChenVBArendallWB3rdHeaddJJMolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallogr D Biol Crystallogr201066Pt1122110.1107/S090744490904207320057044
   PubMedGoogle Scholar
• StudioDDiscovery “Version 21”San Diego (CA)Accelrys2008
   Google Scholar
• LaskowskiRAHutchinsonEGMichieADWallaceACJonesMLThorntonJMPDBsum: a web-based database of summaries and analyses of all PDB structuresTrends Biochem Sci1997224884909433130
   PubMed Web of Science ®Google Scholar
• ThomasSJoelFModestVKChristianRData warrior: an open-source program for chemistry aware data visualization and analysisJ Chem Inf Model201555246047310.1021/ci500588j25558886
   PubMed Web of Science ®Google Scholar
• MorrisGMHueyRLindstromWAutoDock4 and AutoDock-Tools4: automated docking with selective receptor flexibilityJ Comput Chem200930162785279110.1002/jcc.2125619399780
   PubMed Web of Science ®Google Scholar
• PronkSPállSSchulzRGROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics20132984585410.1093/bioinformatics/btt05523407358
   PubMed Web of Science ®Google Scholar
• OostenbrinkCVillaAMarkAEVan GunsterenWFA biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6J Comput Chem2004251656167610.1002/jcc.2009015264259
   PubMed Web of Science ®Google Scholar
• SchüttelkopfAWvan AaltenDMFPRODRG: a tool for high-throughput crystallography of protein-ligand complexesActa Crystallogr D Struct Biol20046013551363
   Google Scholar
• AshrafZImranMAminSSynthesis, characterization and in vitro hydrolysis studies of ester and amide prodrugs of dexibuprofenMed Chem Res2012213361336810.1007/s00044-011-9866-z
   Web of Science ®Google Scholar
• EastonDFHow many more breast cancer predisposition genes are there?Breast Cancer Res199911141710.1186/bcr611250676
   PubMedGoogle Scholar
• CampeauPMFoulkesWDTischkowitzMDHereditary breast cancer: new genetic developments, new therapeutic avenuesHum Genet20081241314210.1007/s00439-008-0529-118575892
   PubMed Web of Science ®Google Scholar
• Irminger-FingerIRatajskaMPilyuginMNew concepts on BARD1: regulator of BRCA pathways and beyondInt J Biochem Cell Biol20167211710.1016/j.biocel.2015.12.00826738429
   PubMed Web of Science ®Google Scholar
• FriedensonBThe BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersBMC Cancer2007715210.1186/1471-2407-7-15217683622
   PubMed Web of Science ®Google Scholar
• CampbellSJEdwardsRAGloverJNComparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1Structure201018216717610.1016/j.str.2009.12.00820159462
   PubMed Web of Science ®Google Scholar
• PalSAn insilico drug designing approach to target the BRCA1 protein involved in breast cancerHelix201661761765
   Google Scholar
• ThangarajPMolecular docking of bioactive compounds against BRCA and COX proteinsPharmacological Assays of Plant-Based Natural Products Progress in Drug ResearchJuckerEM712016181183
   Google Scholar
• PeterEBernhardRPaulSFast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport propertiesJ Med Chem2000433714371711020286
   PubMed Web of Science ®Google Scholar
• GhoseAKHerbertzTHudkinsRLDorseyBDMallamoJPKnowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discoveryACS Chem Neurosci20123503:5010.1021/cn300122k22267984
   PubMed Web of Science ®Google Scholar
• KadamRURoyNRecent trends in drug-likeness prediction: a comprehensive review of in silico methodsIndian J Pharm Sci20076960961510.4103/0250-474X.38464
   Google Scholar
• BakhtMAYarMSAbdel-HamidSGAl-QasoumiSISamadAMolecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivativesEur J Med Chem2010455862586910.1016/j.ejmech.2010.07.06920965619
   PubMed Web of Science ®Google Scholar
• TianSWangJLiYLiDXuLHouTThe application of in silico drug-likeness predictions in pharmaceutical researchAdv Drug Deliv Rev20158621010.1016/j.addr.2015.01.00925666163
   PubMed Web of Science ®Google Scholar
• HassanMAshrafZAbbasQRazaHSeoSYExploration of novel human tyrosinase inhibitors by molecular modeling, docking, and simulation studiesInterdiscip Sci20162110.1007/s12539-016-0171-x
   Web of Science ®Google Scholar
• CosconatiSForliSPerrymanALHarrisRGoodsellDSOlsonAJVirtual screening with AutoDock: theory and practiceExpert Opin Drug Discov2010559760710.1517/17460441.2010.48446021532931
   PubMed Web of Science ®Google Scholar
• HopkinsALGroomCRAlexALigand efficiency: a useful metric for lead selectionDrug Discov Today2004943043110.1016/S1359-6446(04)03069-715109945
   PubMed Web of Science ®Google Scholar
• RavichandranRSundararajanRIn silico-based virtual drug screening and molecular docking analysis of phytochemical derived compounds and FDA approved drugs against BRCA1 receptorJ Cancer Prev Curr Res201780026810.15406/jcpcr.2017.08.00268
   Google Scholar
• PeriasamyJKurdekarVJJastiSTargeting phosphopeptide recognition by the human BRCA1 tandem BRCT domain to interrupt BRCA1-dependent signalingCell Chem Biol201825667769010.1016/j.chembiol.2018.02.01229606576
   PubMed Web of Science ®Google Scholar